ARTICLE | Clinical News
Meabco preclinical data
December 18, 2006 8:00 AM UTC
In a mouse model of tumor, BP-Cx-1plus cis-platin led to 5-6 times lower toxicity than the equivalent dosage of cis-platin alone. The combination also achieved a much higher efficacy in the reduction ...